Skip to main content

Table 3 Volumes of selected brain areas at baseline and end of study

From: Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy

  Treatment (μl) Placebo (μl) P value
  Baseline 1 year Baseline 1 year  
Left amygdala 2,051 1,952 1,797 1,552 0.019
Left hippocampal 2,866 2,761 2,790 2,747 0.56
Right amygdala 2,082 1,992 1,829 1,628 0.20
Right hippocampal 2,944 2,866 2,972 2,814 0.50